Building a resilient portfolio means thinking beyond a single asset or market trend. Economic cycles shift, sectors rise and fall, and no one investment performs well in every environment. That's why many investors look to diversify with platforms that provide access to real estate, fixed-income opportunities, professional financial guidance, precious metals, and even self-directed retirement accounts. By spreading exposure across multiple asset classes, it becomes easier to manage risk, capture steady returns, and create long-term wealth that isn't tied to the fortunes of just one company or industry. The developer has become increasingly vocal about Ethereum’s founding ethos in recent months. The timing of his rallying cries coincides with increased institutional adoption of the blockchain and excitement around its potential for tokenization. Buterin last month urged developers exploring intersections between Ethereum and AI to focus on use cases that foster human freedoms rather than simply pursuing artificial general intelligence. Buterin’s remarks come as he says people are growing increasingly concerned about control and surveillance by governments and corporations and how AI could interact with them. The goal is "de-totalization," Buterin said, referring to a scenario where humans are able to avoid a life controlled by a single entity. He named Starlink, Signal and X community notes as examples of technologies developers should aspire to while discouraging attempts "to be Apple or Google." He added that developers should build full-stack ecosystems from the wallet to AI-powered interfaces and hardware. Maximize saving for your retirement and cut down taxes: Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation . Build your own AI-powered index in minutes — and earn an uncapped 1% match when you move your portfolio to Public. Learn how it works. "Ethereum should conceptualize ourselves as being part of an eco...

Key Points Disney stock is at a 10-month low, but it might not last. The media giant in track to continue delivering double-digit earnings growth through at least the next two fiscal years. The arrival of new CEO Josh D'Amaro next week could be a game changer. 10 stocks we like better than Walt Disney › Shares of Walt Disney (NYSE: DIS) have buckled below $100 again. It's the first time in more than 10 months that the entertainment giant isn't trading in the triple digits. It's an odd stock chart for a company that has more good news than bad in that span of time, but the markdowns aren't entirely unjustified. Disney is a provider of premium travel experiences worldwide, vulnerable when the global economy is coming under fire. Inflationary pressures are percolating, especially with the cost of the fuel required to get families going on road trips and on airplanes to get to its leading theme parks skyrocketing. With more money now going to fill up the tank -- as well as the unemployment rate creeping higher -- there will be less money to go around to hit up the multiplex, subscribe to premium streaming video services, and hop on a cruise ship. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Advertisers also tend to pare back when the economy is iffy. Why pay up for a lead when the target of that campaign is less likely to part with shrinking disposable income? This may seem like a villainous turn for the company that's been crafting happy endings for the past 100 years, but it's always darkest before the dawn -- of a turnaround? I think the House of Mouse could be bottoming out here. In the words of its iconic Carousel of Progress attraction, it could be a great, big, beautiful tomorrow. Whistle while you work Fiscal 2025 was respectable. Revenue rose a mere 3%, but adjusted earnings and free cash ...

jetcityimage Ollie’s Bargain Outlet ( OLLI ) reports fourth quarter results before the market opens on Thursday, March 12, with consensus estimates looking for an adjusted profit of $1.41 per share on $783.7M in sales, an increase of 18% and 17% from a year ago, respectively. For RBC Capital analyst Steven Shemesh, the discount retailer should report a solid quarter with comparable sales expected to increase 3.5% thanks to a strong second half of December, an encouraging result given that December is typically the toughest comparison of the quarter. But for the current quarter, the results could be “noisier” thanks to Winter Storm Fern, although improving throughout March as higher tax refunds are paid. Looking towards Ollie’s ( OLLI ) 2026 performance, Shemesh thinks investors “underappreciate” the company’s earnings power as fears of lapping Big Lots’ share gains are overblown. Big Lots share gains shouldn’t be viewed as a one-time event, Shemesh argues, especially if the stores remain closed. “Ollie’s isn’t a high-frequency store, so ex-Big Lots shopper conversion could happen over several years,” he adds. “After a few years of disruption from higher supply chain costs, subpar distribution center throughput, and a high promotional retail environment, OLLI is nearly back to delivering on-algorithm results. We expect continued progress to result in strong earnings growth and modest multiple expansion,” Shemesh says in his note. For that reason, he maintains his Outperform outlook for the stock with a $147 price target, representing 35% upside to Friday's close. Ollie’s Bargain Outlet ( OLLI ) is viewed favorably by both Seeking Alpha authors and Wall Street analysts with a Buy consensus. Seeking Alpha’s Quant rating also considers Ollie’s a Buy with a Quant score of 3.74 out of 5. More on Ollie's Bargain Outlet Ollie's Bargain Outlet Is A Way To Invest In Retail Sector Weakness Ollie's Bargain Outlet Holdings: Visible Low-Teens Earnings Growth Ollie's Bargain Outle...

enGene Holdings press release ( ENGN ): Q1 GAAP EPS of $0.44. As of January 31, 2026, cash, cash equivalents and marketable securities were $312.5 million. Total operating expenses were $31.2 million for the three months ended January 31, 2026, compared to $26.6 million for 2025. More on enGene Holdings enGene: Two Major Catalysts On Deck For 2nd Half Of 2026 enGene Holdings: A Potential Oncology Entrant enGene extends momentum with another 14% surge on Friday enGene Holdings GAAP EPS of $2.29 Seeking Alpha’s Quant Rating on enGene Holdings

Under Federal Pressure, More Gender Clinics Halt Procedures On Minors Authored by Janice Hisle via The Epoch Times, Mounting political, financial, and legal pressures are poised to put more youth gender clinics out of business - or could force them to scale back services. During the first two months of 2026, about a half-dozen U.S. gender clinics announced they would pause or discontinue some treatment programs for minors, according to hospital announcements and news reports reviewed by The Epoch Times. The curtailment trend , which began in 2021 when states began passing laws to ban medical interventions on minors, picked up steam last year when President Donald Trump issued a wide-ranging executive order to guard against what he calls “surgical and chemical mutilation” of children—procedures that advocates refer to as “gender-affirming care.” A wave of clinic closures and increased restrictions followed, buoyed by a mid-2025 Supreme Court ruling that upheld Tennessee’s statewide ban on medical transitions for minors. And this year, in a landmark verdict , a New York jury awarded a woman $2 million in a gender-transition medical malpractice case; many similar cases are pending. Within days of the Jan. 30 decision, two major medical organizations—the American Society of Plastic Surgeons and the American Medical Association—recommended delaying transition procedures until adulthood. Several clinics that ended some gender treatments last month emphasized that mental health services would remain unaffected. University of Utah Health confirmed that it will “discontinue hormonal transgender treatment for all patients under the age of 18, effective April 15, 2026,” an emailed statement said. NYU Langone Health released a statement last month in which it cited a hospital leadership change and “the current regulatory environment” as reasons for stopping its Transgender Youth Health Program. New York state Sen. Kristen Gonzalez said she considers those treatments “essential ...

Listen for the latest from Bloomberg News

宁德时代：关于拟注册发行债券的公告 富途牛牛

Amazon’s Zoox is testing robotaxi operations in 10 U.S. cities, but Google’s Waymo has a big lead.

This megacap AI stock pays over $12 billion in annual dividends thestreet.com

美国总统特朗普称现在谈论扣押伊朗石油为时过早 2026-03-10 01:22:35 来源： 同花顺7x24快讯 分享 美国总统特朗普称现在谈论扣押伊朗石油为时过早。

Abstract Aerial Art/DigitalVision via Getty Images Rigetti ( RGTI ) closed out 2025 with modest revenue but strong technical momentum, capping a year CEO Dr. Subodh Kulkarni described as one of meaningful progress. In 2025, we made great progress across fidelity, scale, and system architecture…Our focus continues to be on achieving practical quantum advantage, and over the past year we validated key elements of our strategy, including improved two-qubit gate fidelity across both monolithic and chiplet-based systems and continued momentum in scaling our superconducting quantum technology. Despite the wins for the quarter, which I’ll discuss in a second , the stock slipped post-earnings. Rigetti actually beat EPS estimates by 40%, with a non-GAAP loss of $0.03 against the consensus at $0.04. Shares fell roughly 4.3% in after-market trading, with the pain point being the revenue miss. The top line came in at $1.9 million, missing the consensus by 30%. But context matters here, because the stock was already down about 4.13% heading into the print, partially due to the overall market pullback on the geopolitical uncertainty, so, along with peers, it was under pressure even before the numbers dropped. And this kind of reaction is pretty on-brand for Rigetti, as the correlation between earnings performance and price action has historically been ambiguous. The stock is down around 4% on Monday as well, along with peers, as seen below. Webull The stock is down around 26.5% year to date, along with IonQ ( IONQ ) down another 23.6%, Quantum Computing ( QUBT ) down 28.6%, D-Wave Quantum ( QBTS ) down 31.7%, and Arqit ( ARQQ ) down another 31.5%, all against the S&P 500 up around 2.2% during the same period. YChart This is pretty much par for the course with quantum names. Ever since Google's ( GOOG ) Willow chip announcement sent the entire sector into a frenzy late last year, these stocks have been on a wild ride, massive run-ups driven by retail enthusiasm and headline moment...

Petrobras is holding off on retail fuel price increases in Brazil despite the war-driven surge in global oil markets, said Chief Executive Officer Magda Chambriard . The state-controlled oil company will wait and see if and for how long crude prices remain elevated before deciding whether to pass those costs on the consumers, Chambriard said during a Bloomberg Television interview in New York on Monday. “We are looking closely all these events and we will react in the right moment,” she said. “We have to be sure this is not a quick tendency, and that the scenario is reasonably stable to allow us to go in the right direction”. As the US-Israel war with Iran enters its second week, crude prices have surpassed $100 a barrel, pulling everything from jet fuel and gasoline to the building blocks of plastics higher. Saudi Arabia and other major Middle East oil and natural gas producers have begun to throttle output as missiles, drone attacks and the virtual shutdown of a key shipping route strangle the industry. Read More: Oil Soars Above $100 as Iran War Forces Saudi Production Cuts The gap between Petrobras’s refinery-gate fuel prices and international levels has widened since the conflict kicked off on Feb. 28. Petrobras is selling diesel and gasoline for 85% and 45% less than international prices, respectively, according to fuel-importers association Abicom. So far, there’s been no political pressure on Petrobras to restrain pump prices, Chambriard said. Petroleo Brasileiro SA, as the Rio de Janeiro-based producer is formally known, has a policy of shielding Latin America’s largest economy from sharp swings in fuel prices.

(RTTNews) - European stocks went sliding down south Monday morning, with many of the markets falling to multi-month lows, as deepening conflict in the Middle East, and rising concerns about inflation due the steep rise in oil prices rendered the mood extremely bearish. Brent crude futures, which rose to a nearly four-year high to $119.50 a barrel earlier, dropped to around $100 later on in the day, but still remained nearly 8% up from Friday's close. Tensions in the Gulf escalated following reports of explosions at Al Udeid Air Base, the largest United States military installation in the Middle East. Bahrain's state oil company has declared force majeure on its shipments after Iranian strikes in the region set the largest oil facility on fire. An unexpected drop in German industrial production in the month of January and a sharp drop in German factors weighed as well. Some of the markets in the region recovered some lost ground and trimmed their losses as the day progressed. The slump was widespread in most of the markets across Europe, and stocks from financials, mining, industrials and aviation sectors were some of the worst hit. The pan European Stoxx 600 closed down 0.62%. The U.K.'s FTSE 100 ended 0.34% down, Germany's DAX settled lower by 0.82% and France's CAC 40 fell 0.98%. Switzerland's SMI dropped 0.73%. Among other markets in Europe, Austria, Belgium, Czech Republic, Finland, Greece, Iceland, Ireland, Portugal, Spain, Sweden and Türkiye ended with sharp to moderate losses. Denmark and Poland declined marginally, while Netherlands, Norway and Russia closed higher. In the UK market, Persimmon, Intertek Group, Segro, British Land, JD Sports Fashion, Mondi, Land Securities, Easyjet, Anglo American Plc, IMI and LondonMetric Property ended lower by 3%-6% Marks & Spencer, Standard Life, Weir Group, Melrose Industries, Smith & Nephew, Aviva, Convatec Group, M&G, Rolls-Royce Holdings, Antofagasta and Reckitt Benckiser also declined sharply. Metlen Energy & Metals ...

Editor's note: Seeking Alpha is proud to welcome Systems Capital as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access. Click here to find out more » Frazao Studio Latino/E+ via Getty Images Thesis Tilray’s been going on a massive acquisition spree in recent years. Not only have they merged with Aphria in 2020 to make the largest cannabis company in the world by revenue, but in a short 6 years, they’ve become an international craft beer behemoth. However, communications from management focus on how great they will be, but how are they now? Tilray has the potential to be an excellent buy for the long-term, and they are currently poised to be the future leader of the adult consumer products industry. Their shares are currently on a fire-hot sale, selling around $7. Is now the time to buy though? I’d say hold unless you want to weather the storm. Tilray has a lot on their plate. After going through an acquisition spree, introducing new brands, bringing new products and new markets to Tilray’s portfolio, and expanding their global footprint they’ve seen a lot of massive changes under current CEO Irwin D Simon. When will the acquisitions end though? They’ll likely continue introducing new brands to their brand portfolio while they stabilize internal manufacturing and distribution pipelines for the next few years. I discuss this in greater detail later in the article. Until their brands can generate revenue greatly beyond their appetite for acquisition, their net profit will remain below or near $0 . They’ve grown their cannabis and alcohol brand portfolio to the size of a small behemoth, but that is only a fourth of their total operations. They still have a small wellness products line, a distribution business, and an ingredient wholesale business that I believe will grow in the coming years, so they’re worth keeping an ...

Gerry Adams is as culpable for IRA bombings on the UK mainland as the individuals who planted and detonated the devices, the high court has heard at the beginning of a civil trial. The former Sinn Féin leader is being sued for symbolic “vindicatory” damages of £1 each by John Clark, Jonathan Ganesh and Barry Laycock, who were injured respectively in the 1973 Old Bailey bombing, and the London Docklands and Manchester bombings in 1996. They allege that Adams, who is credited with helping to bring about the Northern Ireland peace process, “was an instrumental force in the organisation of the PIRA [provisional IRA] and building of the two-strand attack – ArmaLite and the ballot box. A foot in each camp.” Opening the claimants’ case in London on Monday, Anne Studd KC, said in written submissions: “Their focus is to shine a light upon the involvement of the defendant in the PIRA in the course of that conflict and to prove on balance of probabilities that he [Adams] was so intrinsically involved in the PIRA organisation that he is as culpable for the assaults giving rise to these claims as the individuals who planted and detonated the bombs.” She added: “There is no doubt that the defendant contributed to the peace in Northern Ireland, but the claimants say that on the evidence he also contributed to the war.” Studd told the court that Adams admitted to his involvement with the IRA to a special branch officer after being arrested in 1972 and, in the same year, attended two meetings with government officials “as a member of PIRA and had authority to act on the organisation’s behalf”. The claimants’ case is also relying on evidence from IRA volunteers including Dolours Price, one of nine individuals imprisoned in 1973 for the Old Bailey bombing, as well as Troubles-era intelligence officials. Additionally, Studd claimed that, while detained under internment in the 1970s, Adams began writing a weekly column for the Republican News under the pen name Brownie, including a 1976...

When it comes to the health and wellness industry, Peloton Interactive seems to have gotten most of the attention over the past several years. There's a better business that investors should look at if they want exposure to this market, though. Consider Planet Fitness (PLNT 2.72%), mainly because it has solid fundamentals. The fitness club operator's shares have been very volatile, and they trade 29% below their peak (as of March 4). If you think this is a possible buy-the-dip investment candidate, take the time to learn these three things first. 1. Expanding the physical footprint Growth has been the key factor driving this business. A decade ago, at the end of 2015, there were 1,124 Planet Fitness locations. As of Dec. 31, 2025, there were 2,896 clubs in total, with a small presence in Canada, Panama, Mexico, Australia, and Spain. The leadership team believes that there's potential for 5,000 in the U.S. over the long term. Planet Fitness now has 20.8 million members, a massive figure that makes it one of the largest such chains in the world. Despite a choppy macroeconomic environment, the customer base is significantly larger than it was five years ago. Even though it increased the base membership's monthly fee from $10 to $15 in 2024, Planet Fitness still maintains its "high-value, low-price" positioning. But getting more people to upgrade to the $25.99-per-month Black Card, which comes with added perks, is lucrative. The current penetration rate is near 67%. 2. Copying the fast-food playbook Large fast-food enterprises are known for adopting franchise business models. Planet Fitness operates the same way. It's worth noting that just 10% of its locations are actually owned by the company. This setup allows the business to scale up in a more efficient and capital-light manner, reducing the need for large investments. There is robust demand to open Planet Fitness gyms, as signed agreements are in place to open 750 new clubs. Newer locations are growing their sales ...

Key Points Planet Fitness has significantly expanded its store footprint, with no plans to let up. Operating a franchise business model should theoretically lift profits at a faster rate than revenue. This stock doesn’t trade at a cheap valuation, so investors will have to decide if it’s worth the price. 10 stocks we like better than Planet Fitness › When it comes to the health and wellness industry, Peloton Interactive seems to have gotten most of the attention over the past several years. There's a better business that investors should look at if they want exposure to this market, though. Consider Planet Fitness (NYSE: PLNT), mainly because it has solid fundamentals. The fitness club operator's shares have been very volatile, and they trade 29% below their peak (as of March 4). If you think this is a possible buy-the-dip investment candidate, take the time to learn these three things first. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » 1. Expanding the physical footprint Growth has been the key factor driving this business. A decade ago, at the end of 2015, there were 1,124 Planet Fitness locations. As of Dec. 31, 2025, there were 2,896 clubs in total, with a small presence in Canada, Panama, Mexico, Australia, and Spain. The leadership team believes that there's potential for 5,000 in the U.S. over the long term. Planet Fitness now has 20.8 million members, a massive figure that makes it one of the largest such chains in the world. Despite a choppy macroeconomic environment, the customer base is significantly larger than it was five years ago. Even though it increased the base membership's monthly fee from $10 to $15 in 2024, Planet Fitness still maintains its "high-value, low-price" positioning. But getting more people to upgrade to the $25.99-per-month Black Card, which comes with added per...

格隆汇3月10日｜美国总统特朗普：谈论缴获伊朗石油还为时尚早。

Micron Investors Just Got Terrible News From Nvidia The Globe and Mail

(RTTNews) - Regeneron Pharmaceuticals said olatorepatide, an investigational obesity treatment it licensed from Hansoh Pharmaceutical Group, delivered positive Phase 3 trial results in Chinese patients with obesity or overweight. The randomized, double-blind, placebo-controlled study enrolled 604 adults across 33 clinical sites in mainland China and evaluated once-weekly doses of 5 mg, 10 mg and 15 mg of olatorepatide over 48 weeks. Results showed participants receiving the therapy achieved up to 19% average weight loss from baseline at week 48, while up to 97% of treated patients lost at least 5% of body weight, meeting the trial's co-primary endpoints. "We are encouraged by the olatorepatide Phase 3 results in this Chinese population, which demonstrate not only meaningful weight loss but also a tolerability profile that could make a real difference in patients' day-to-day experience on treatment," said George D. Yancopoulos, M.D., Ph.D., Board co-Chair, President, and Chief Scientific Officer at Regeneron. "We are on track to advance into our registrational program later this year and are eager to see the results from our pivotal trials." Olatorepatide, a dual GLP-1/GIP receptor agonist, also demonstrated a favorable gastrointestinal tolerability profile. Reported rates of nausea were below 10%, while vomiting incidence was below 5%, with relatively low treatment discontinuation. Under the companies' agreement, Hansoh retains development and commercialization rights in Greater China, while Regeneron holds exclusive development and commercial rights outside mainland China, Hong Kong and Macau. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

格隆汇3月10日｜伊朗外长阿拉格齐：伊朗将对美国的阴谋做出许多“惊喜回应”。

伊朗局勢｜特朗普與普京通電話 俄方稱對話坦誠具建設性 To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video 【有線新聞】美國總統特朗普跟俄羅斯總統普京通電話，稱對方想在中東問題上提供協助。 特朗普形容二人對話氣氛良好，磋商中東及俄烏局勢，普京有意幫忙化解中東衝突，不過他認為結束俄烏戰事會更有幫助。俄羅斯總統助理烏沙科夫說二人對話坦誠及具建設性，普京就緩解伊朗衝突提出數項建議，重申要盡快透過政治和外交手段解決問題。烏沙科夫引述特朗普在通話中交代美國和以色列聯合行動的現況評估，但沒有交代詳情。

Biopharma bites: Incyte's regulatory whiplash, NovaBridge's AMD data, plus the Rapport-Tenacia deal FirstWord Pharma